Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
European Heart Journal Open|November 24, 2025
Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysisAlberto Aimo, Vincenzo Castiglione, Michele Emdin, et al.
Heart (British Cardiac Society)|March 13, 2021
Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failureAlberto Aimo, Concetta Prontera, Claudio Passino, et al.
Archives of Gerontology and Geriatrics|September 10, 2016
Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patientsAntonio Teixeira, Mattia Arrigo, Giuseppe Vergaro, et al.
European Journal of Internal Medicine|February 15, 2026
Redefining optimal medical therapy for heart failure in amyloid transthyretin cardiomyopathyAlberto Aimo, Michele Emdin, Giuseppe Vergaro, et al.
International Journal of Cardiology|March 31, 2012
Prognostic value of plasma renin activity in heart failure patients with chronic kidney diseaseRoberta Poletti, Giuseppe Vergaro, Luc Zyw, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2025
Cardiac amyloidosis: Innovations in diagnosis and treatmentVincenzo Castiglione, Sabrina Montuoro, Giulia Orlando, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 1, 2020
α-1 Antitrypsin as a potential biomarker in chronic heart failureValter Lubrano, Giuseppe Vergaro, Maristella Maltinti, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[Ten perspectives for research and innovation in cardiac amyloidosis]Aldostefano Porcari, Alberto Aimo, Giuseppe Vergaro, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 24, 2023
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosisMichele Emdin, Paolo Morfino, Lucia Crosta, et al.
Journal of Cardiovascular Development and Disease|August 25, 2022
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and BeyondPaolo Morfino, Alberto Aimo, Vincenzo Castiglione, et al.
Pageof 21